Cédric Logé

6PUBLICATIONS
32CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMolecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2025
Synthesis and Biological Evaluation of Itraconazole Derivatives: Design in an Old Scaffold.

Shuai Zhong, Apollonia Kalamatianou, Gonzalo Scalese

|Jun 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.

Lhana Tisseur, Cédric Logé, Sandrine Cojean

|Dec 17, 2024
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.

Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama

|Nov 13, 2021
Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases.

Viet Hung Dao, Isabelle Ourliac-Garnier, Cédric Logé

|Aug 07, 2021
Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives.

Qi Liu, Shiying Li, Amandine Dupuy

|Feb 10, 2021
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.

Bruno Oyallon, Marie Brachet-Botineau, Cédric Logé

Pageof 1

Frequent Collaborators

4 joint publications

Stéphane Bach

3 joint publications

Pascal Marchand

3 joint publications

Marc-Antoine Bazin

3 joint publications

Blandine Baratte